FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice
Open Access
- 14 June 2022
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 43 (9) , 5333-5341
Abstract
Background: The early differential diagnosis among neurodegenerative parkinsonian disorders becomes essential to set up the correct clinical-therapeutic approach. The increased utilization of [18F] fluoro-deoxy-glucose positron emission tomography (FDG PET) and the pressure for cost-effectiveness request a systematic evaluation and a validation of its utility in clinical practice. This retrospective study aims to consider the contribution, in terms of increasing accuracy and increasing diagnostic confidence, of voxel-based FDG PET analyses in the differential diagnosis of these disorders, including Parkinson’s disease, multiple system atrophy, progressive supranuclear palsy, and cortico-basal syndrome. Method: Eighty-three subjects with a clinically confirmed diagnosis of degenerative parkinsonian disorders who underwent FDG brain PET/CT were selected. A voxel-based analysis was set up using statistical parametric mapping (SPM) on MATLAB to produce maps of brain hypometabolism and relative hypermetabolism. Four nuclear physicians (two expert and two not expert), blinded to the patients’ symptoms, other physicians’ evaluations, and final clinical diagnosis, independently evaluated all data by visual assessment and by adopting metabolic maps. Results: In not-expert evaluators, the support of both hypometabolism and hypermetabolism maps results in a significant increase in diagnostic accuracy as well as clinical confidence. In expert evaluators, the increase in accuracy and in diagnostic confidence is mainly supported by hypometabolism maps alone. Conclusions: In this study, we demonstrated the additional value of combining voxel-based analyses with qualitative assessment of brain PET images. Moreover, maps of relative hypermetabolism can also make their contribution in clinical practice, particularly for less experienced evaluators.Keywords
Funding Information
- Università degli Studi di Firenze
This publication has 32 references indexed in Scilit:
- PET/CT in diagnosis of movement disordersAnnals of the New York Academy of Sciences, 2011
- PET/CT in diagnosis of dementiaAnnals of the New York Academy of Sciences, 2011
- Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stagesBrain Structure and Function, 2010
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodiesEuropean Journal of Neurology, 2007
- Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degenerationMovement Disorders, 2006
- Diagnosis and management of dementia with Lewy bodiesNeurology, 2005
- Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysisNeuroscience Letters, 2005
- FDG PET in the differential diagnosis of parkinsonian disordersNeuroImage, 2005
- Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's diseaseAnnals of Neurology, 1993